now $NBRV The approval next week is a huge catalyst, however what sold me was the Merck deal. Think about it, Merck just doesn't partner on whim. The way the contract agreement was prepared leads me to believe this company has alot in store and we are only seeing the beginning. I was going to make this a short play, but I'm now here long term.
  • 8